Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
The American Journal of Psychiatry
|
September 1, 2022
Psychotherapy's Role for Treatment-Resistant Depression?
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Benzodiazepines for schizophrenia
Markus Dold, Chunbo Li, Magdolna Tardy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 3, 2023
Silexan for treatment of anxiety and depression in the context of COVID-19
Lucie Bartova, Markus Dold, Gernot Fugger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 27, 2016
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials
Markus Dold, Magdolna Tardy, Myrto T Samara, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 9, 2022
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
Lucie Bartova, Markus Dold, Hans-Peter Volz, et al.
JAMA Psychiatry
|
February 5, 2016
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis
Myrto T Samara, Markus Dold, Myrsini Gianatsi, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 30, 2023
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans-Peter Volz, et al.
Journal of Affective Disorders
|
December 20, 2017
Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
Paolo Olgiati, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 26, 2018
Rapid antidepressant effect of S-ketamine in schizophrenia
Lucie Bartova, Konstantinos Papageorgiou, Ivan Milenkovic, et al.
The Journal of ECT
|
May 19, 2017
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report
Lucie Bartova, Ana Weidenauer, Markus Dold, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
The American Journal of Psychiatry
|
September 1, 2022
Psychotherapy's Role for Treatment-Resistant Depression?
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Benzodiazepines for schizophrenia
Markus Dold, Chunbo Li, Magdolna Tardy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 3, 2023
Silexan for treatment of anxiety and depression in the context of COVID-19
Lucie Bartova, Markus Dold, Gernot Fugger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 27, 2016
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials
Markus Dold, Magdolna Tardy, Myrto T Samara, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 9, 2022
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
Lucie Bartova, Markus Dold, Hans-Peter Volz, et al.
JAMA Psychiatry
|
February 5, 2016
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis
Myrto T Samara, Markus Dold, Myrsini Gianatsi, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 30, 2023
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans-Peter Volz, et al.
Journal of Affective Disorders
|
December 20, 2017
Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
Paolo Olgiati, Alessandro Serretti, Daniel Souery, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 26, 2018
Rapid antidepressant effect of S-ketamine in schizophrenia
Lucie Bartova, Konstantinos Papageorgiou, Ivan Milenkovic, et al.
The Journal of ECT
|
May 19, 2017
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report
Lucie Bartova, Ana Weidenauer, Markus Dold, et al.
Page
of 7